• BCL-XL Inhibitor A-1155463: Research Guide

  2026-08-26

  BCL-XL inhibitor A-1155463 is a selective small-molecule tool with a reported Ki of 19 nM and activity in BCL-XL-dependent cancer models. This guide separates product-dossier specifications from peer-reviewed evidence on apoptotic priming, drug resistance in solid tumors, and hematological malignancies research.

• LuQi Formula, SPTLC2, and Post-MI Remodeling

  2026-08-25

  A 2025 Phytomedicine study identifies SPTLC2-regulated de novo ceramide synthesis as a mechanistic link between myocardial infarction and ventricular remodeling. Using rat and cardiomyocyte models, the authors show that LuQi Formula reduces ceramide accumulation and apoptosis while improving post-infarction cardiac function.

• Sunitinib Workflows for RCC and Angiogenesis

  2026-08-25

  Build reproducible Sunitinib assays that connect RTK blockade with tumor-cell survival, angiogenesis, and drug resistance. The workflow also translates a syringin combination study into practical sensitivity, apoptosis, and pathway-validation experiments.

• Ibuprofen: COX Inhibition and Research Use

  2026-08-24

  Ibuprofen, also known as 2-[4-(2-methylpropyl)phenyl]propanoic acid, inhibits COX-1 and COX-2 and is used in inflammation, pain, and cell-based research models. Supplier-reported data also describe anti-proliferative activity in HCT-116 colon carcinoma cells, with solvent and storage controls required for reproducible experiments.

• Fluo-4 AM Maps Calcium Signaling in Diabetic Nephropathy

  2026-08-23

  A translational framework for using Fluo-4 AM to interrogate the GPR107–AT1R–Ca2+ pathway implicated in diabetic nephropathy, with practical guidance for assay design, validation, and mechanistic interpretation.

• Everolimus (RAD001) Cancer Assay Workflow

  2026-08-22

  Build more informative mTOR inhibition experiments with Everolimus (RAD001), from stock preparation and dose-response design to paired proliferation and cell-death measurements. The workflow helps distinguish cytostatic effects from true killing in cancer models while improving assay reproducibility and translational interpretation.

• Regulatory Cross-Talk in A40926 Biosynthesis

  2026-08-21

  This study shows that pathway-specific regulators from teicoplanin and A40926 biosynthetic clusters are not uniformly interchangeable, despite functional or evolutionary similarities. Its cross-complementation experiments identify regulator compatibility as a practical variable in glycopeptide antibiotic strain engineering and reveal a LuxR-like regulator that can enhance teicoplanin production.

• Steroid Lysis of Protoplasts: Mechanistic Insights

  2026-08-20

  Smith and Shay used osmotically fragile Sarcina lutea protoplasts to distinguish direct membrane lysis from effects requiring an intact bacterial cell wall. Their protection and antagonism experiments implicated membrane disruption as a major mechanism for several synthetic antimicrobial steroids and established a practical framework for mechanistic antimicrobial testing.

• A40926: From Biosynthetic Logic to Translation

  2026-08-20

  A mechanistic and translational perspective on A40926, linking cell-wall inhibition, pathway-specific regulation, assay design, resistant-pathogen research, and the development of dalbavancin-related antibacterial strategies.

• TUNEL Apoptosis Detection Kit: Glioma Workflow

  2026-08-19

  Build a practical TUNEL assay workflow for C6 glioma cells and brain tissue, from fixation and permeabilization to DAB development and quantitative scoring. The approach translates recent Chrysanthemum indicum L. mechanism research into a spatially resolved apoptosis readout while highlighting controls, optimization points, and common failure modes.

• Cepharanthine: From Mechanism to Translation

  2026-08-19

  Cepharanthine is a biscoclaurine alkaloid whose translational value is becoming clearer as researchers connect apoptosis, DNA-damage signaling, patient-derived organoids, and in vivo disease models. This thought-leadership perspective examines how to position Cepharanthine in endometriosis, cancer, and chemotherapy-support research without overstating preclinical maturity.

• Morning Training Improves Endurance Adaptation in Mice

  2026-08-18

  A recent mouse study shows that endurance training during the early active phase produces faster performance gains than training later in the active phase, even when the early-phase group completes less absolute work. The findings distinguish training efficiency from final performance and highlight glycogen, mitochondrial, and contractile measurements as important components of circadian exercise research.

• Sodium salicylate workflows for NF-κB research

  2026-08-18

  Build reproducible NF-κB, inflammation, and oxidative stress assays with a water-soluble sodium salicylate workflow. The article also shows how this small-molecule comparator can complement, but not replace, stromal-remodeling nanomedicine studies in pancreatic cancer.

• Amikacin (BAY416651): Reliable Cell Assays

  2026-08-17

  Learn how Amikacin (BAY416651) Aminoglycoside Antibiotic, SKU B3431, can support controlled host–pathogen, contamination, and antibiotic-resistance workflows without confusing antibacterial effects with direct cytotoxicity. This scenario-based guide covers mechanism, assay compatibility, preparation, interpretation, and practical product selection.

• TPCA-1 Workflow for IKK-2 Inhibition

  2026-08-17

  TPCA-1 is a selective IKK-2 inhibitor for connecting NF-κB signaling, cytokine release, and inflammatory phenotypes in cell and animal models. This workflow emphasizes dose selection, orthogonal readouts, and safeguards against confusing NF-κB suppression with direct RIPK1-dependent cell-death inhibition.

455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page